JP2004501904A - Ｈｐｖｅ１ヘリカーゼ阻害剤としてのベンゾジアゼピン - Google Patents

Ｈｐｖｅ１ヘリカーゼ阻害剤としてのベンゾジアゼピン Download PDF

Info

Publication number
JP2004501904A
JP2004501904A JP2002505380A JP2002505380A JP2004501904A JP 2004501904 A JP2004501904 A JP 2004501904A JP 2002505380 A JP2002505380 A JP 2002505380A JP 2002505380 A JP2002505380 A JP 2002505380A JP 2004501904 A JP2004501904 A JP 2004501904A
Authority
JP
Japan
Prior art keywords
methyl
dihydro
formula
mmol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002505380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501904A5 (cg-RX-API-DMAC7.html
Inventor
ハースト，デービッド・ナイジェル
ジョーンズ，フィリップ・スティーブン
パークス，ケビン・エドワード・バードン
パーラット，マーチン・ジョン
ウィルソン，フランシス・ザビエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2004501904A publication Critical patent/JP2004501904A/ja
Publication of JP2004501904A5 publication Critical patent/JP2004501904A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2002505380A 2000-06-28 2001-06-19 Ｈｐｖｅ１ヘリカーゼ阻害剤としてのベンゾジアゼピン Pending JP2004501904A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015904.6A GB0015904D0 (en) 2000-06-28 2000-06-28 Inhibitors of HPV E1 helicase enzyme
PCT/EP2001/006895 WO2002000632A1 (en) 2000-06-28 2001-06-19 Benzodiazepines as inhibitors of hpv e1 helicase

Publications (2)

Publication Number Publication Date
JP2004501904A true JP2004501904A (ja) 2004-01-22
JP2004501904A5 JP2004501904A5 (cg-RX-API-DMAC7.html) 2005-02-03

Family

ID=9894630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002505380A Pending JP2004501904A (ja) 2000-06-28 2001-06-19 Ｈｐｖｅ１ヘリカーゼ阻害剤としてのベンゾジアゼピン

Country Status (7)

Country Link
US (1) US6703387B2 (cg-RX-API-DMAC7.html)
EP (1) EP1299364A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004501904A (cg-RX-API-DMAC7.html)
AU (1) AU2001270580A1 (cg-RX-API-DMAC7.html)
CA (1) CA2411157A1 (cg-RX-API-DMAC7.html)
GB (1) GB0015904D0 (cg-RX-API-DMAC7.html)
WO (1) WO2002000632A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1615878B1 (en) 2003-01-14 2012-04-04 Cytokinetics, Inc. Compounds, compositions and methods of treatment for heart failure
ATE411981T1 (de) * 2003-06-10 2008-11-15 Smithkline Beecham Corp Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
CA2528336A1 (en) 2003-06-12 2005-01-20 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
KR101276136B1 (ko) 2004-06-17 2013-06-18 싸이토키네틱스, 인코포레이티드 화합물, 조성물 및 방법
US7176222B2 (en) 2004-07-27 2007-02-13 Cytokinetics, Inc. Syntheses of ureas
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
WO2007070683A2 (en) 2005-12-15 2007-06-21 Cytokinetics, Inc. Certain chemical entities, compositions and methods
WO2007078815A2 (en) 2005-12-16 2007-07-12 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
JP5178526B2 (ja) 2005-12-19 2013-04-10 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
WO2011046646A2 (en) * 2009-07-10 2011-04-21 Microbiotix, Inc. Inhibitors of filovirus entry into host cells
CN102902895B (zh) * 2010-05-18 2017-04-05 小江生物技术有限公司 预防和治疗人乳头瘤病毒感染类疾病的化合物的筛选方法
JP2013010740A (ja) * 2011-06-03 2013-01-17 Sumitomo Chemical Co Ltd イソキサゾリン化合物を製造する方法
EP3367798A1 (en) 2015-10-28 2018-09-05 Syngenta Participations AG Microbiocidal oxadiazole derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1455048A (fr) * 1965-01-09 1966-04-01 Clin Byla Ets Composés de la série des benzodiazépines et leur préparation
TW219896B (cg-RX-API-DMAC7.html) * 1988-07-07 1994-02-01 Duphar Int Res
US4847129A (en) * 1988-09-16 1989-07-11 Continental Pet Technologies, Inc. Multilayer preform for hot fill containers
US5141735A (en) * 1990-06-18 1992-08-25 Hoffman-La Roche, Inc. Substituted amino-benzodiazepines having anitviral activity
BR9913226A (pt) * 1998-09-01 2001-05-22 Innogenetics Nv Benzodiazepinas e derivados de benzotiazepinas e peptìdios de hbsag ligados a anexinas, suas composições e uso
CA2342858A1 (en) * 1998-09-04 2000-03-16 Institute Of Molecular & Cell Biology Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv

Also Published As

Publication number Publication date
AU2001270580A1 (en) 2002-01-08
US6703387B2 (en) 2004-03-09
WO2002000632A1 (en) 2002-01-03
EP1299364A1 (en) 2003-04-09
GB0015904D0 (en) 2000-08-23
CA2411157A1 (en) 2002-01-03
US20020128262A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
JP2004501904A (ja) Ｈｐｖｅ１ヘリカーゼ阻害剤としてのベンゾジアゼピン
JP6680683B2 (ja) テトラヒドロ−ベンゾジアゼピノン類
TWI406857B (zh) 關於診斷與治療有關蝟狀途徑之病理學疾病的新穎化合物、其醫藥組合物及用途
US6828315B1 (en) 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
OA12147A (en) PyrroloÄ2,3dÜpyrimidine compositions and their use.
RU2113437C1 (ru) Замещенные пиримидины, или их фармацевтически приемлемые соли, или n-оксиды, способы их получения и фармацевтическая композиция на их основе
CA2409998A1 (en) Benzodiazepine derivatives as app modulators
US20040152888A1 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
EP1851225B1 (en) Pyrazolo-pyrimidine derivatives as mglur2 antagonists
UA76798C2 (uk) Заміщені 1,4-бензодіазепіни та їх використання для лікування раку, фармацевтична композиція (варіанти) на їх основі та спосіб лікування захворювань (варіанти)
EP2271646A1 (en) Apoptosis signal-regulating kinase 1 inhibitors
JPH10510512A (ja) 尿素誘導体とａｃａｔ阻害剤としての用途
CN1880317B (zh) 作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶
TW200418861A (en) Pyrrolopyridazine derivatives
HUP0301269A2 (hu) Ftalazinonszármazékok és ezeket tartalmazó gyógyszerkészítmények
CN1964944A (zh) 作为抗病毒药的吲哚衍生物
AU2788792A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
TW202110845A (zh) 三環化合物
JP4980358B2 (ja) Ｃ型肝炎感染症を治療するためのベンゾジアゼピン誘導体
US3429874A (en) 1-polyhalogenoalkyl-2-oxo-1,3-dihydro-2h-1,4-benzodiazepines
EP1812112B1 (en) Benzodiazepine derivatives as ROCK kinases inhibitors
JP2007538068A (ja) 新規な縮合複素環およびそれらの使用
JPH09509957A (ja) 免疫調節剤としてのキノリン誘導体
JP3012338B2 (ja) アリールおよびヘテロアリールアルコキシナフタレン誘導体
EP0595924B1 (en) Platelet activating factor antagonists

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060919

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061218

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070605